Cesarean SectionCROSSNCT01211600
Cesarean Trial of Staples vs. Sutures
A study testing Staples and Suture in people with Cesarean Section and Wound Complications, run by Thomas Jefferson University at 2 sites in United States.
Trial summary
To determine whether the rate of wound complications differs based on method of closure of skin incision (staples vs. suture) after cesarean delivery. Read more about this study
- Who is it for?
- Any age, women onlyHealthy volunteers can take part
- Conditions the study is for
- Cesarean Section, Wound Complications, Patient Satisfaction
- What is being tested?
- Staples and Suture
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 746 participants
- Where
- 2 sitesUnited States
- Study dates
- Jun 2010to Dec 2014
- Phase
- Interventional
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- Women only
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Women undergoing cesarean delivery for pregnancy greater than 23 weeks gestation.
Who cannot join
- Poorly controlled diabetes (defined as ≥ 50% of fasting or 2 hour postprandial glucose levels > 95 and 120 respectively within the week prior to delivery),
- Vertical skin incisions
- Chronic steroid use
- Active lupus flare
- HIV/AIDS
- Current treatment for cancer or a history of radiation to the abdomen/pelvis
Show all 10Show fewer
- Current treatment with immunosuppressant medications secondary to history of transplantation
- Emergency cesarean(precluding informed consent prior to surgery)
- Lack of access to a phone
- Allergy to suture or staple material
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Yale University
New Haven, Connecticut
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107
About this study
Official title: Cesarean Randomized Control Trial Of Sutures vs. Staples (CROSS)
To determine whether the rate of wound complications differs based on method of closure of skin incision (staples vs. suture) after cesarean delivery.
Read the detailed description
Despite this large number of cesareans performed annually, there is a paucity of data to suggest which technique is superior for closure of the skin incision with regards to wound complications, including wound separation and infection. As the morbidity associated with a cesarean delivery is usually related to wound complications, especially infection, we feel that it is important to examine this outcome by comparing the current skin closure techniques: staples versus suture.
- Being tested
- Staples, Suture
- Keywords
- Staples, Sutures, Wound infections, Cosmesis, Aesthetic appearance of skin incision
- Medical subject headings
- Patient Satisfaction, Wound Infection
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
StaplesOther
Also called Closure Technique
Interrupted Ethicon Staples
SutureOther
Also called Closure Technique
Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle)
| Study group | Role | What they receive |
|---|---|---|
| Staples | Active comparator | Interrupted Ethicon Staples Receives: Other: Staples |
| Suture | Active comparator | Subcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle) Receives: Other: Suture |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of Participants With Wound Complications
The primary outcome is to evaluate the rate of wound complications for patients undergoing cesarean whose skin incision is closed with staples versus with suture.
Wound complications included infection, hematoma, seroma, and separation and readmission for wound complication.
Measured: Within 6 weeks of postpartum
Secondary outcomes (12)
Patient Scar Assessment Scale Scores for Evaluation of Cosmesis
Patient evaluation of cosmesis of the cesarean incision based on closure method: staples vs sutures.
Surgical scars were evaluated using Patient Scar Assessment Scale (PSAS). The PSAS evaluates six items: pain, itchiness, color, stiffness, thickness, and irregularity. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 6-60. Lower scores indicate closer resemblance to normal skin and are superior.
Measured: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Patient Satisfaction With Closure Method and Scar Appearance
Whether the patient's satisfaction with the incision differed based on closure method (staples vs sutures) using 10-point Likert scale on which 1 is completely dissatisfied and 10 is completely satisfied.
Measured: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Pain Perception
Whether the patient's perception of pain associated with the incision differed based on closure method (staples vs sutures). Patients were asked to rate pain on a scale from 0 (no pain) to 10 (extreme pain) using a visual graph of facial expressions.
Measured: Immediately postpartum to time of discharge, which is typically 3-4 days post-cesarean
Additional Provider Visits
Mean number of visits per participant (All wound visits, number of visits for women who were diagnosed with wound complications, number of visits for women who were not diagnosed with a wound complication).
Measured: Within 6 weeks postpartum
Number of Participants With Primary Versus Repeat Cesarean
Randomization stratum - BMI (over/under 30) and Cesarean (primary or repeat)
Measured: At randomization.
Intraoperative Trial Details - Duration of Operation and Skin Closure
Duration of operation: skin incision to skin closure Duration of skin closure: fascial closure to skin closure
Measured: Time of Cesarean
Intraoperative Trial Details - Closure of Subcutaneous Tissue
Number of participants requiring subcutaneous tissue closure
Measured: Time of Cesarean
Length of Hospital Stay
Length of hospital stay (days)
Measured: Immediate postpartum.
Number of Participants That Received Anticoagulation Within 24 Hours
Number of participants that received anticoagulation within 24 hours of procedure (preoperatively or postoperatively)
Measured: Within 24 hours postpartum.
Number of Participants Diagnosed With Endomyometritis
Number of participants diagnosed with endomyometritis requiring antibiotics
Measured: Immediate postpartum.
Change in Hemoglobin Pre-operatively to Post-operatively
Median change in hemoglobin from preoperative value (g/dL) to post-operatively.
Measured: Up to 72 hours before and 24 hours after cesarean.
Observer Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.
Surgical scars were evaluated using Observer Scar Assessment Scale (OSAS). The OSAS evaluates five items: vascularity, pigmentation, thickness, relief, and pliability. Each item is scored on a 10-point scale comparing the patient's skin to normal skin, in which one represents normal skin. The score is summed, range 5-50. Lower scores indicate closer resemblance to normal skin and are superior.
Measured: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Sep 2010 (estimated)
- Study startJun 2010
- Primary completionOct 2014
- Study completionDec 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (6)Papers the sponsor has linked to this study.
- Other trials for Cesarean SectionStudies of the same condition, open and under way.
- More trials run by Thomas Jefferson UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 746 participants (actual)
Sponsor and investigators
- Lead sponsor
- Thomas Jefferson University
- Sponsor type
- University, hospital or other
- Collaborators
- Main Line Health
- Responsible party
- Sponsor
- Investigators
- A. Dhanya Mackeen, MD, MPH, Principal investigator, Thomas Jefferson University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01211600
- Sponsor's protocol ID
- 10D.199
- Acronym
- CROSS
- Status last verified
- Nov 2019
- First submitted
- 28 Sep 2010
- Last updated
- 26 Nov 2019
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Publications
Rousseau JA, Girard K, Turcot-Lemay L, Thomas N. A randomized study comparing skin closure in cesarean sections: staples vs subcuticular sutures. Am J Obstet Gynecol. 2009 Mar;200(3):265.e1-4. doi: 10.1016/j.ajog.2009.01.019.
PubMed 19254586Frishman GN, Schwartz T, Hogan JW. Closure of Pfannenstiel skin incisions. Staples vs. subcuticular suture. J Reprod Med. 1997 Oct;42(10):627-30.
PubMed 9350017Alderdice F, McKenna D, Dornan J. Techniques and materials for skin closure in caesarean section. Cochrane Database Syst Rev. 2003;(2):CD003577. doi: 10.1002/14651858.CD003577.
PubMed 12804476Basha SL, Rochon ML, Quinones JN, Coassolo KM, Rust OA, Smulian JC. Randomized controlled trial of wound complication rates of subcuticular suture vs staples for skin closure at cesarean delivery. Am J Obstet Gynecol. 2010 Sep;203(3):285.e1-8. doi: 10.1016/j.ajog.2010.07.011.
PubMed 20816153Mackeen AD, Khalifeh A, Fleisher J, Han C, Leiby B, Berghella V. Pain Associated With Cesarean Delivery Skin Closure: A Randomized Controlled Trial. Obstet Gynecol. 2015 Oct;126(4):702-707. doi: 10.1097/AOG.0000000000001043.
PubMed 26348166Mackeen AD, Khalifeh A, Fleisher J, Vogell A, Han C, Sendecki J, Pettker C, Leiby BE, Baxter JK, Sfakianaki A, Berghella V. Suture compared with staple skin closure after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2014 Jun;123(6):1169-1175. doi: 10.1097/AOG.0000000000000227.
PubMed 24807325
Study at a glance
From the registry record, last updated by the sponsor on 26 Nov 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Cesarean Randomized Control Trial Of Sutures vs. Staples (CROSS)
- ClinicalTrials.gov ID
- NCT01211600
- Acronym / sponsor ID
- CROSS / 10D.199
- Keywords
- Staples, Sutures, Wound infections, Cosmesis, Aesthetic appearance of skin incision
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 746 participants (actual)
- Lead sponsor
- Thomas Jefferson UniversityUniversity, hospital or other
- Collaborators
- Main Line Health
- Study start
- Jun 2010
- Primary completion
- Oct 2014 (actual)
- Study completion
- Dec 2014 (actual)
- First posted
- 29 Sep 2010 (estimated)
- Results
- Posted 26 Nov 2019
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To determine whether the rate of wound complications differs based on method of closure of skin incision (staples vs. suture) after cesarean delivery.
Detailed description
Despite this large number of cesareans performed annually, there is a paucity of data to suggest which technique is superior for closure of the skin incision with regards to wound complications, including wound separation and infection. As the morbidity associated with a cesarean delivery is usually related to wound complications, especially infection, we feel that it is important to examine this outcome by comparing the current skin closure techniques: staples versus suture.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Staples | Active comparator | Other: StaplesInterrupted Ethicon Staples |
| Suture | Active comparator | Other: SutureSubcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle) |
Who may qualify
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- Women undergoing cesarean delivery for pregnancy greater than 23 weeks gestation.
Key exclusion criteria (10 listed)
- Poorly controlled diabetes (defined as ≥ 50% of fasting or 2 hour postprandial glucose levels > 95 and 120 respectively within the week prior to delivery),
- Vertical skin incisions
- Chronic steroid use
- Active lupus flare
- HIV/AIDS
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| StaplesAlso: Closure TechniqueInterrupted Ethicon Staples | Other | Staples |
| SutureAlso: Closure TechniqueSubcuticular continuous suture (4-0 Monocryl Plus on PS2 needle or 4-0 Vicryl Plus on FS2 or PS2 needle) | Other | Suture |
Primary outcome
Number of Participants With Wound Complications
Time frame: Within 6 weeks of postpartum
The primary outcome is to evaluate the rate of wound complications for patients undergoing cesarean whose skin incision is closed with staples versus with suture. Wound complications included infection, hematoma, seroma, and separation and readmission for wound complication.
12 secondary outcomes
Patient Scar Assessment Scale Scores for Evaluation of Cosmesis
Time frame: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Patient Satisfaction With Closure Method and Scar Appearance
Time frame: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Pain Perception
Time frame: Immediately postpartum to time of discharge, which is typically 3-4 days post-cesarean
Additional Provider Visits
Time frame: Within 6 weeks postpartum
Number of Participants With Primary Versus Repeat Cesarean
Time frame: At randomization.
Intraoperative Trial Details - Duration of Operation and Skin Closure
Time frame: Time of Cesarean
Intraoperative Trial Details - Closure of Subcutaneous Tissue
Time frame: Time of Cesarean
Length of Hospital Stay
Time frame: Immediate postpartum.
Number of Participants That Received Anticoagulation Within 24 Hours
Time frame: Within 24 hours postpartum.
Number of Participants Diagnosed With Endomyometritis
Time frame: Immediate postpartum.
Change in Hemoglobin Pre-operatively to Post-operatively
Time frame: Up to 72 hours before and 24 hours after cesarean.
Observer Evaluation of Cosmesis of the Cesarean Incision Based on Closure Method: Staples vs Sutures.
Time frame: Immediately postpartum and 4 - 8 weeks after intervention, up to 12 weeks.
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Nov 2019.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Background: PubMed 19254586Rousseau JA, Girard K, Turcot-Lemay L, Thomas N. A randomized study comparing skin closure in cesarean sections: staples vs subcuticular sutures. Am J Obstet Gynecol. 2009 Mar;200(3):265.e1-4. doi: 10.1016/j.ajog.2009.01.019.
- Background: PubMed 9350017Frishman GN, Schwartz T, Hogan JW. Closure of Pfannenstiel skin incisions. Staples vs. subcuticular suture. J Reprod Med. 1997 Oct;42(10):627-30.
- Background: PubMed 12804476Alderdice F, McKenna D, Dornan J. Techniques and materials for skin closure in caesarean section. Cochrane Database Syst Rev. 2003;(2):CD003577. doi: 10.1002/14651858.CD003577.
- Background: PubMed 20816153Basha SL, Rochon ML, Quinones JN, Coassolo KM, Rust OA, Smulian JC. Randomized controlled trial of wound complication rates of subcuticular suture vs staples for skin closure at cesarean delivery. Am J Obstet Gynecol. 2010 Sep;203(3):285.e1-8. doi: 10.1016/j.ajog.2010.07.011.
- Derived from this study: PubMed 26348166Mackeen AD, Khalifeh A, Fleisher J, Han C, Leiby B, Berghella V. Pain Associated With Cesarean Delivery Skin Closure: A Randomized Controlled Trial. Obstet Gynecol. 2015 Oct;126(4):702-707. doi: 10.1097/AOG.0000000000001043.
- Derived from this study: PubMed 24807325Mackeen AD, Khalifeh A, Fleisher J, Vogell A, Han C, Sendecki J, Pettker C, Leiby BE, Baxter JK, Sfakianaki A, Berghella V. Suture compared with staple skin closure after cesarean delivery: a randomized controlled trial. Obstet Gynecol. 2014 Jun;123(6):1169-1175. doi: 10.1097/AOG.0000000000000227.
Related trials for Cesarean Section
Not yet recruiting
Esketamine Combined With Transcutaneous Electrical Acupoint Stimulation on Postoperative Recovery Quality After Elective Cesarean Section
Cesarean Section (MeSH: D002585), Postoperative Pain After Cesarean Section
Not yet recruitingObservational study
Early Heart Rate Variability and Sleep and Quality of Recovery After Cesarean Delivery
Recovery of Function, Postoperative Period
Not yet recruiting
Virtual Reality for Anxiety and Birth Satisfaction During Elective Cesarean Section
Anxiety, Cesarean Section
RecruitingPhase 4
Adding Dexmedetomidine or Clonidine to Spinal Anesthesia for Cesarean Delivery
Cesarean Delivery, Cesarean Delivery; Neuraxial Opioids
Recruiting
Reducing Chronic Pain Following Cesarean Delivery
Chronic Pain, Cesarean Section Complications
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
A. Dhanya Mackeen, MD, MPH principal investigator
Thomas Jefferson University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Staples and Suture in people with Cesarean Section and Wound Complications, run by Thomas Jefferson University at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Nov 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 26 Nov 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of Participants With Wound Complications (time frame: Within 6 weeks of postpartum). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01211600, which also lists 6 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Nov 2019; AzTrials last refreshed its copy on 6 Nov 2026.